Last reviewed · How we verify
NCT05224700: JAPI
Early Development of Academic Skills in the Classroom
NA trial testing JAPI in General Population of Children Aged 3 to 5 Years Old in 754 participants. Status unknown.
30 July 2022
Quick facts
| Lead sponsor | University of Talca |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 754 |
| Start date | 1 March 2022 |
| Primary completion | 30 July 2022 |
| Estimated completion | 30 March 2025 |
Drugs / interventions tested
- JAPI
- Painting group
Conditions studied
- General Population of Children Aged 3 to 5 Years Old — all drugs for General Population of Children Aged 3 to 5 Years Old →
Sponsor
University of Talca
Who can join
Adults 3 to 5, any sex, with General Population of Children Aged 3 to 5 Years Old. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a two-arm cluster randomized controlled trial. The two arms will be: 1) Intervention group, where the stimulation program will be implemented; and 2) Comparison group (active). The aim of this study is: To evaluate the effectiveness of a program aimed at stimulating cognitive (working memory and inhibitory control), emotional (emotion recognition), and social competence skills (choice of prosocial behaviors) for the development of initial literacy learning and pre-calculation in socioeconomically disadvantaged preschoolers immediately after the intervention and at 6, 12, 18, and 24 months post intervention, controlling for gender, mental health, and baseline state of the skills stimulated. The intervention program, which targets cognitive, emotional, and social competence skills, was designed for socioeconomically disadvantaged preschoolers in order to stimulate their working memory, inhibitory control, emotion recognition, and choice of prosocial behaviors during the development of the academic skills of initial literacy learning and pre-calculation. Immediately after the completion of the intervention program, participants are expected to show improvements in these skills and the academic skills of initial literacy learning and pre-calculation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effectiveness of a tablet-based video game that stimulates cognitive, emotional, and social skills in developing academic skills among preschoolers: study protocol for a randomized controlled trial.
Rojas-Barahona CA, Gaete J, Véliz M, Castillo RD, et al · · 2022 · cited 3× · PMID 36352445 · DOI 10.1186/s13063-022-06875-9
Verify or expand the search:
- PubMed search for NCT05224700
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Talca trials
Trials by the same sponsor.
- NCT07053267 — Acute Postprandial Effects of Functional Ice Cream With Cimarrón Bean Extrudate in Adults · NA · completed
- NCT07076563 — Ice Cream Enriched With Cimarrón Bean Extrudate and Cardiovascular Risk in Adults · NA · active not recruiting
- NCT06935656 — Effectiveness of Three Executive Function Interventions on Direct and Far Transfer in Chilean School Children · NA · completed
- NCT07043829 — Cimarrón Bean Extrudate Solution on Platelet Function and Biochemical Parameters · NA · completed
- NCT06516874 — A Pilot Study of Trauma-Focused Cognitive-Behavioral Therapy for Treatment of Post-traumatic Stress in Adults. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05224700 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Talca
- Last refreshed: 2 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05224700.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing